Respiratory diseases such as Asthma and Chronic Obstructive Pulmonary Disease (COPD) are on the rise partly because of ...
Companies are advancing treatments to better control symptoms of chronic obstructive pulmonary disease ...
If you start to experience symptoms like chest pain, blue lips, or coughing up more than a teaspoon of blood, you should see ...
New findings from the ERS Global Congress on Lung Diseases present a paradigm shift in COPD treatment: Early identification of type 2 inflammation and personalized biologic therapy.
Angina, a symptom of underlying heart disease, is frequently overlooked in women despite being a leading cause of death.
Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...
When breathing becomes a daily battle, even the simplest acts can feel exhausting. Now, a new study has found the key to ...
TipRanks on MSN
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Sanofi (($SNYNF)) announced an update on their ongoing clinical study. Sanofi is conducting a study titled ‘A Phase 2b/3, Randomized, ...
Doing targeted COPD case finding as part of NHS lung cancer checks could save £33m over the next decade, research has shown.
The COPD Action Alliance today released a new white paper, COPD in America and the Road to Better Care, outlining the urgent need for federal policymakers to recognize chronic obstructive pulmonary ...
The respiratory medical community is moving toward shared decision-making in self-managing chronic respiratory disease, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results